Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.
Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area ...
Hormone therapy for breast cancer is not the same as hormone replacement therapy at menopause, in which hormones are given to reduce the symptoms that can be associated with menopause.
In women with a history of breast cancer, using hormone replacement therapy (HRT) didn’t increase the risk of breast cancer recurrence or death. The findings of this latest, small study add to a ...
Doru Paul, MD, is a board-certified oncologist and hematologist. He is an associate professor of clinical medicine at Weill Cornell Medical College. Breast cancer treatment includes an array of ...
A UAB clinical trial gave Rebecca Hall years beyond a terminal HER2-positive breast cancer diagnosis, highlighting how innovative therapies and research at the O’Neal Cancer Center are improving ...
In this review, we provide a concise overview of neoadjuvant systemic therapy in early-stage HER2-positive breast cancer, with a focus on various chemotherapy backbones and de-escalation strategies.
The most promising outcome of the test, developed by the University of North Carolina, was that over 68% of patients with ...
Radiation therapy is an effective and widely used treatment for breast cancer. While the benefits of radiation therapy for breast cancer are clear, long-term complications related to radiation therapy ...
More physicians are discussing hormone replacement therapy with breast cancer survivors when menopause hits.
Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...
A discovery in mice reveals why fasting enhances a type of breast cancer treatment — a hormone-signalling pathway and gene-expression changes have key roles. Stephen D. Hursting is in the Department ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results